Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Italy / NCT06831487
Enrolling by invitation Not applicable

Analysis of Line-Field Confocal Optical Coherence Tomography (LC-OCT) in Characterization of Gingival Systemic Health, Gingivitis and Periodontitis

NCT06831487 · tracked via the Priya Life Science Italy tracker
Sponsor
University of Catania
Phase
Not applicable
Started
2025-01-02
Last updated
2025-02-18

Condition(s) studied

Gingival Diseases

Investigational drug(s) / intervention(s)

Line-Field Confocal Optical Coherence Tomography (LC-OCT)

Line-Field Confocal Optical Coherence Tomography (LC-OCT): Analysis of Line-Field Confocal Optical Coherence Tomography (LC-OCT) in separate groups of patients with gingivitis, periodontitis and healthy patients

Study summary

The aim of the study is to identify tissue changes among healthy patients, patients with gingivitis and with periodontitis before and after treatment, by analyzing tissues changes through Line-Field Confocal Optical Coherence Tomography (LC-OCT)

Eligibility

Sex
ALL
Min age
18 Years
Max age
75 Years
Healthy volunteers
No
Inclusion Criteria: * Diagnosis of gingivitis or periodontitis by the presence of elevated bleeding or probing index or probing pocket depth Exclusion Criteria: * Smoking * Any systemic diseases that could influence the gingival structure

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Policlinico G. Rodolico Catania Italy

More University of Catania trials in Italy

Auditory Functions in Patients With Multiple Sclerosis Recruiting
Impact of Non-surgical Periodontal Therapy in the Improvement of Early Endothelial Dysfunction in Subjects With Peri-implantitis and Peri-implant Mucositis Recruiting
Impact of Non-surgical Periodontal Treatment on Targeted Metabolomics Recruiting
Chemokine Receptors on CD8+ T Cells in Patients With Bipolar Disorder Starting soon
Effects of Enamel Matrix Derivative in the Treatment of Peri-implant Mucositis Enrolling by invitation

Other trials for the same condition

Gingival Phenotype and Dental Crowding in Pediatric Patients Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06831487 on ClinicalTrials.gov ↗ ← All trials in Italy